Advy Japan Co,ltd Pharmaceutical Import Profile — Japan (DGFT 2022–2026)

Name: Advy Japan Co,ltd Pharmaceutical Import Records from India — 2 Products, $822.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Advy Japan Co,ltd — Pharmaceutical Importer Profile (2026) | 2 Products, $822.8K Trade | TransData Nexus

Advy Japan Co,ltd

Pharmaceutical Importer · Japan · Medical Devices & Diagnostics Focus · $822.8K Total Trade · DGFT Verified

Advy Japan Co,ltd is a pharmaceutical importer based in Japan with a total trade value of $822.8K across 2 products in 1 therapeutic categories. Based on 246 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Advy Japan Co,ltd sources from 1 verified Indian supplier, with Advy Chemical Private Limited accounting for 100.0% of imports.

Advy Japan Co,ltd — Import Portfolio & Supplier Network

Advy Japan Co,ltd import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Advy Japan Co,ltd?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Advy Chemical Private Limited	$404.9K	126	100.0%

Advy Japan Co,ltd sources from 1 verified Indian supplier across 17 distinct formulations. The sourcing is highly concentrated — Advy Chemical Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Diagnostic reagents goat anti-human	$196.0K	9
Diagnostic reagents goat anti-human	$71.3K	6
Diagnostic reagents goat anti-human	$46.8K	8
Diagnostic reagents goat anti- human	$43.0K	1
Diagnostic reagents goat anti -human	$21.8K	4
Diagnostic reagents goat anti-human iga	$10.4K	4
Diagnostic reagents c reactive	$9.3K	1
Diagnostic reagents anti-crp serum	$4.4K	24
Diagnostic reagents normal goat serum	$1.8K	2
Diagnostic reagents goat anti-human	$0	1
Diagnostic reagents goat anti-human	$0	1
Diagnostic reagents anti-crp serum	$0	58
Diagnostic reagents goat anti -human	$0	2
Diagnostic reagents anti-crp serum	$0	2
Goat anti-human igg (fc)	$0	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Diagnostic	Medical Devices & Diagnostics	$411.4K	123	2.2%	7
2	Reagent	Medical Devices & Diagnostics	$411.4K	123	3.1%	5

Advy Japan Co,ltd imports 2 pharmaceutical products across 1 categories into Japan totaling $822.8K.

Advy Japan Co,ltd — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Advy Japan Co., Ltd. is a pharmaceutical importer and buyer headquartered in Tokyo, Japan. Established on April 1, 2008, the company operates from the Kanda No.4 Park Building in Chiyoda-ku, Tokyo. The managing director is Mr. Toshiro Hijikata, with Mr. Bharat Daftary and Mr. Syd Daftary serving as board members. (advy-japan.jp)

As an affiliate of Bharat Serums and Vaccines Limited (BSVL), a leading Indian pharmaceutical company, Advy Japan Co., Ltd. specializes in the import and distribution of pharmaceutical raw materials, medical devices, diagnostic reagents, and related products. The company plays a pivotal role in introducing BSVL's products and services to the Japanese market, ensuring compliance with local regulations and meeting the specific needs of Japanese healthcare providers. (advy-japan.jp)

2Distribution Network

Advy Japan Co., Ltd. operates its distribution network from its Tokyo headquarters, strategically located to facilitate efficient logistics and supply chain management within Japan. While specific warehouse locations are not publicly disclosed, the company's central position in Tokyo enables effective distribution across the country. The company leverages its affiliation with BSVL to access a global network of suppliers and partners, enhancing its ability to source and deliver a diverse range of pharmaceutical products to the Japanese market. (advy-japan.jp)

3Industry Role

In Japan's pharmaceutical supply chain, Advy Japan Co., Ltd. functions primarily as an importer and distributor of pharmaceutical raw materials and diagnostic reagents. By sourcing products from its parent company, BSVL, and other global suppliers, Advy Japan ensures a steady supply of essential medical products to Japanese healthcare providers. The company's role is crucial in bridging international pharmaceutical innovations with the Japanese market, adhering to local regulatory standards and addressing the specific needs of Japanese patients and medical professionals. (advy-japan.jp)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Advy Japan Co,ltd

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Advy Japan Co., Ltd. demonstrates a high level of sourcing concentration, with a total import value of $823,000 USD from India across 246 shipments, primarily from a single supplier, Advy Chemical Private Limited. This single-source dependency indicates a strategic choice to maintain a consistent and reliable supply chain, leveraging the established relationship with Advy Chemical to ensure product quality and availability. The substantial volume of imports from this supplier suggests a stable and long-term partnership, reducing the risks associated with supplier diversification. However, this concentration also means that any disruptions at Advy Chemical could significantly impact Advy Japan's operations, highlighting the importance of robust contingency planning and risk management strategies.

2Supply Chain Resilience

The resilience of Advy Japan Co., Ltd.'s supply chain is closely tied to its reliance on Advy Chemical Private Limited for the majority of its imports. While this single-source strategy offers consistency, it also exposes the company to potential risks such as supply disruptions or quality issues from the supplier. The limited number of unique suppliers and formulations imported suggests a lack of diversification, which could be a vulnerability in the event of unforeseen challenges. To enhance supply chain resilience, Advy Japan may consider identifying and establishing relationships with additional suppliers, diversifying its product portfolio, and developing contingency plans to mitigate potential disruptions.

Importing Pharmaceuticals into Japan — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Japan

1Regulatory Authority & Framework

In Japan, the regulation of pharmaceutical products is overseen by the Ministry of Health, Labour and Welfare (MHLW), which enforces the Pharmaceutical and Medical Device Act (PMD Act). This legislation governs the import, manufacture, and sale of pharmaceuticals, ensuring that all products meet stringent safety and efficacy standards. The PMD Act outlines the requirements for marketing authorization, quality control, and post-market surveillance, providing a comprehensive framework for pharmaceutical operations within Japan. (selling-in-japan.jp)

2Import Licensing & GMP

To import pharmaceutical products into Japan, companies must obtain the necessary licenses under the PMD Act. This includes securing an import license from the MHLW, which authorizes the company to import and distribute pharmaceutical products within Japan. Additionally, imported products must comply with Good Manufacturing Practice (GMP) standards recognized by the MHLW. While Japan has its own GMP guidelines, it also accepts certifications from other reputable standards, such as EU GMP, WHO GMP, and PIC/S, provided they meet the MHLW's criteria. This recognition facilitates international trade and ensures that imported products adhere to Japan's rigorous quality standards. (selling-in-japan.jp)

Quality & Labeling

Advy Japan Co,ltd — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Advy Japan Co., Ltd. focuses on importing diagnostic reagents and related pharmaceutical preparations, including antigens, antibodies, and control sera, primarily from Advy Chemical Private Limited. This strategic focus aligns with the growing demand for advanced diagnostic tools in Japan's healthcare sector, driven by an aging population and the need for accurate and timely disease detection. By specializing in these products, Advy Japan positions itself as a key supplier of essential diagnostic materials, contributing to improved patient outcomes and supporting the efficiency of medical diagnostics in Japan. (advy-japan.jp)

2Sourcing Profile

Advy Japan Co., Ltd. employs a sourcing strategy that heavily relies on its parent company, Advy Chemical Private Limited, for the supply of diagnostic reagents and pharmaceutical preparations. This approach ensures consistency in product quality and leverages the established relationship between the two entities. The focus on specific formulations, such as antigens and antibodies, reflects a targeted procurement strategy aimed at meeting the specialized needs of the Japanese diagnostic market. While this strategy offers advantages in terms of supply chain efficiency and product consistency, it also highlights the importance of maintaining a robust and resilient supply chain to mitigate potential risks associated with supplier dependency. (advy-japan.jp)

Market Positioning

Seller's Guide — How to Become a Supplier to Advy Japan Co,ltd

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

For new Indian suppliers, there is a realistic opportunity to collaborate with Advy Japan Co., Ltd. by offering complementary products or alternative formulations that align with the diagnostic reagents and pharmaceutical preparations currently imported. Diversifying Advy Japan's supplier base could enhance supply chain resilience and provide access to a broader range of products for the Japanese market. Identifying gaps in Advy Japan's current sourcing strategy, such as specific diagnostic reagents or pharmaceutical preparations not currently imported, presents an opportunity for new suppliers to meet these unmet needs. Establishing partnerships with Advy Japan could lead to mutual benefits, including expanded market reach and enhanced product offerings.

2Requirements & Qualifications

Indian exporters seeking to supply products to Advy Japan Co., Ltd. must ensure that their products comply with Japan's regulatory standards, including obtaining the necessary import licenses under the Pharmaceutical and Medical Device Act. Products must adhere to Good Manufacturing Practice (GMP) standards recognized by the Ministry of Health, Labour and Welfare, such as EU GMP, WHO GMP, or

Frequently Asked Questions — Advy Japan Co,ltd

What products does Advy Japan Co,ltd import from India?

Advy Japan Co,ltd imports 2 pharmaceutical products across 1 categories. Top imports: Diagnostic ($411.4K), Reagent ($411.4K).

Who supplies pharmaceuticals to Advy Japan Co,ltd from India?

Advy Japan Co,ltd sources from 1 verified Indian suppliers. The primary supplier is Advy Chemical Private Limited (100.0% of imports, $404.9K).

What is Advy Japan Co,ltd's total pharmaceutical import value?

Advy Japan Co,ltd's total pharmaceutical import value from India is $822.8K, based on 246 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Advy Japan Co,ltd focus on?

Advy Japan Co,ltd imports across 1 categories. The largest: Medical Devices & Diagnostics (100.0%).

Get Full Advy Japan Co,ltd Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.